Clinical trials
Presbyopia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
333 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 3 |
| 2007 | 1 |
| 2008 | 5 |
| 2009 | 10 |
| 2010 | 11 |
| 2011 | 8 |
| 2012 | 8 |
| 2013 | 6 |
| 2014 | 19 |
| 2015 | 14 |
| 2016 | 17 |
| 2017 | 23 |
| 2018 | 24 |
| 2019 | 20 |
| 2020 | 25 |
| 2021 | 24 |
| 2022 | 34 |
| 2023 | 22 |
| 2024 | 22 |
| 2025 | 23 |
| 2026 | 12 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 229 |
| Unknown status | 40 |
| Recruiting | 18 |
| Terminated | 16 |
| Not yet recruiting | 13 |
| Withdrawn | 8 |
| Active, not recruiting | 8 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alcon Research | 36 |
| Democritus University of Thrace | 20 |
| CooperVision, Inc. | 16 |
| AcuFocus, Inc. | 11 |
| Beaver-Visitec International, Inc. | 10 |
| CIBA VISION | 9 |
| Johnson & Johnson Vision Care, Inc. | 9 |
| Technolas Perfect Vision GmbH | 9 |
| LENZ Therapeutics, Inc | 8 |
| Allergan | 7 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Presbyopia | 333 |
| Cataract | 78 |
| Myopia | 53 |
| Refractive Errors | 43 |
| Astigmatism | 28 |
| Hyperopia | 28 |
| Aphakia | 13 |
| Pseudophakia | 9 |
| Eye Diseases | 7 |
| Asthenopia | 4 |
Trials
Showing 26 to 50 of 333. Each trial links to its page on Pharma Observatory.
233 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.